Israeli Prime Minister Benjamin Netanyahu announced on Monday that the Israeli government will provide $60 million towards efforts to develop a COVID-19 vaccine.

Netanyahu announced the pledge in a pre-recorded video during a European Commission-hosted virtual marathon to raise money for the World Health Organization, Bill and Melinda Gates Foundation, and other organizations worldwide working on a vaccine.

“Global plague eradication requires global partnership,” said Netanyahu. “Israel, like all countries, was significantly affected by the plague. Fortunately, the number of victims we have so far is relatively low. This is the result of early action to stop the virus, advanced technology used to track those infected, first-rate medical experts and a disciplined population that largely obeyed the government’s containment policy.”

He acknowledged that while Israel and other countries are starting to reopen their economies, the pandemic can only truly end when a vaccine is developed.

“We must all work together on improving diagnostics, accelerating therapies and ultimately developing a vaccine,” he said. “I am confident that Israel’s leading research institutions, its world-renowned scientists and our unique culture of innovation can enable us to play an important role in advancing solutions on all three fronts.”

Other participants in the event included British Prime Minister Boris Johnson, French President Emmanuel Macron, Jordan’s King Abdullah II and Turkish President Recep Tayyip Erdoğan. The United States did not participate in the event.

Various Israeli institutions have been making progress on developing a vaccine. The Galilee Research Institute (MIGAL) is reportedly in the final stages of developing its vaccine and the Israeli Institute for Biological Research has been testing its on rodents. On April 19, Tel Aviv University professor Jonathan Gershoni obtained a patent from the U.S. Patent and Trademark Office for a COVID-19 vaccine; he estimated at the time that he was two-thirds of the way towards completing it.

Dozens of companies around the world are actively working to develop a vaccine, with reportedly at least 100 vaccines in the pipeline. Eight are reportedly in human trials, including two in the United States.

This article was first published by the Jewish Journal.

Support Jewish Journalism
with 2020 Vision

One of the most intriguing stories of the sudden Coronavirus crisis is the role of the internet. With individuals forced into home quarantine, most are turning further online for information, education and social interaction.

JNS's influence and readership are growing exponentially, and our positioning sets us apart. Most Jewish media are advocating increasingly biased progressive political and social agendas. JNS is providing more and more readers with a welcome alternative and an ideological home.

During this crisis, JNS continues working overtime. We are being relied upon to tell the story of this crisis as it affects Israel and the global Jewish community, and explain the extraordinary political developments taking place in parallel.

Our ability to thrive in 2020 and beyond depends on the generosity of committed readers and supporters. Monthly donations in particular go a long way in helping us sustain our operations. We greatly appreciate any contributions you can make during these challenging times. We thank you for your ongoing support and wish you blessings for good health and peace of mind.